基于TERT启动子突变状态对黑色素瘤进行分类
研究对60株黑色素瘤细胞系进行TERT启动子突变、拷贝数、基因表达和端粒长度分析,发现-124/125和-146位点突变与最高TERT表达相关但不影响绝对端粒长度,而rs2853669变异以隐性模型与更长端粒长度显著相关(P=0.003)。结果提示TERT启动子突变谱比既往认知更复杂,且突变与下游表达及端粒长度不一致。
要点
- TERT启动子-124/125和-146突变与最高TERT表达相关,但不影响绝对端粒长度。
- rs2853669变异以隐性模型与更长端粒长度显著相关(P=0.003)。
- TERT启动子突变与TERT表达及端粒长度不持续相关,提示肿瘤细胞可能通过替代机制逃逸端粒缩短。
核心结论
- TERT启动子突变谱比既往认知更复杂,且突变状态与下游TERT表达及端粒长度并不一致。
研究设计与样本
- 使用Sanger测序和实时定量逆转录技术,对60株黑色素瘤细胞系评估TERT启动子突变状态、拷贝数、基因表达和端粒长度。
主要发现
- -124/125和-146位点突变与最高水平TERT基因表达相关,但对绝对端粒长度无明显影响。
- 常见变异rs2853669(-245位点)以隐性模型与更长端粒长度显著相关(P=0.003)。
关键数值与推荐
- rs2853669与更长端粒长度的关联在隐性模型下P=0.003。
临床怎么用
- 提示仅凭TERT启动子突变状态不足以一致预测TERT表达或端粒长度,分类黑色素瘤时需综合考虑下游分子表现。
局限性
- 结果基于纯化的黑色素瘤细胞系实验,非直接来自肿瘤组织。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although TERT promoter mutations have been associated with a worsened prognosis in melanoma, the relationship between mutation status and downstream telomerase activity and telomere length remains convoluted. Using Sanger sequencing and techniques based on quantitative reverse transcriptase in real time, we evaluated 60 melanoma cell lines for TERT promoter mutational status, copy number, gene expression, and telomere length to provide a comprehensive analysis of the TERT/telomere pathway and establish a classification system whereby the associations between TERT mutations and their downstream molecular manifestations can more easily be ascertained. Mutations at positions -124/125 and -146 were associated with the highest levels of TERT gene expression but had no appreciable impact on absolute telomere length. In contrast, the common variant rs2853669 (at position -245) was significantly associated with longer telomere length via a recessive model in our cohort (P = 0.003). Our results, which are from assays performed on purified melanoma cell lines, suggest that the TERT promoter harbors a more complex mutational landscape than previously thought. Furthermore, the failure of TERT promoter mutations to consistently correlate with TERT expression and telomere length suggests an alternative method whereby tumor cells escape the critical shortening of telomeres.
引用
- Shaughnessy M, Njauw CN, Artomov M, et al. Classifying Melanoma by TERT Promoter Mutational Status. J Invest Dermatol. 2019. PMID: 31425705. doi:10.1016/j.jid.2019.06.149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。